Updates / Health Innovation

Blog

By / 3.19.2020

America now depends on overseas suppliers for more than half of its medical equipment and supplies, up sharply from a few years ago. That’s based on a PPI analysis of government trade and industry data, What happened? As we go through this terrible pandemic, U.S. healthcare providers are suffering from a surprising shortage of medical […]

By / 3.17.2020

Is the coronavirus about to force us into the Biotech Century? Here’s a follow-up to my previous post. In response to the coronavirus pandemic, government and private researchers are taking the perhaps unprecedented step of testing the safety of a new coronavirus vaccine in volunteers before testing its safety and efficacy in animals. As one […]

By / 3.15.2020

Can we expect the biopharma folks to quickly find a good treatment for COVID-19? Is it time to bust up regulatory barriers holding back innovation? In March 1997, BusinessWeek magazine, now part of Bloomberg,  ran a cover story entitled “The Biotech Century.” The cover language, in part, said “Thanks to fundamental advances in genetics, biology […]

By / 3.9.2020

It’s the S-word–shortages. The greatest manufacturing nation in the world, but we can’t make enough masks and other protective gear for our frontline healthcare workers? The coronavirus crisis points out what many of us already knew–globalization is not enough to provide the flexibility and surge response that the U.S. needs. Apparently in medical emergencies,  countries […]

By / 7.25.2019

In the first half of 2019, the consumer price index for prescription drugs fell by 0.8% compared to the first half of 2018.  That’s the first year-over-year decline in prescription drug prices since the mid-1970s, according to BLS data. Looking at five-year inflation rates,  the consumer price index for prescription drugs rose at a 2.7% […]

By / 6.7.2019

Here’s a question that progressives should be asking themselves: How can we encourage the development of innovative and effective treatments like Zolgensma? Just approved by the FDA, Zolgensma is a powerful new treatment for Spinal Muscular Atrophy (SMA), which is the leading genetic cause of death in infants and toddlers. Roughly one out of every […]

By / 2.14.2019

America’s massive health care industry faces three major challenges: how to cover everyone, reduce costs, and increase productivity. Telehealth – the use of technology to help treat patients remotely – may help address all three. Telehealth reduces the need for expensive real estate and enables providers to better leverage their current medical personnel to provide […]